Investigating how a specific protein affects lipid metabolism in the brain and its role in aging and neurodegeneration.

Role of TTYH1 in mobilizing lipids and ApoE in glia: Implications for brain aging and neurodegeneration

NIH-funded research Rutgers the State Univ of Nj Newark · NIH-11076644

This study is looking at how a protein called TTYH1 affects fat processing in brain cells, especially as we age and in conditions like Alzheimer's, to help us understand what might go wrong in brain cell function.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionRutgers the State Univ of Nj Newark NIH-funded
Lab location1 site (Newark, United States)
Project IDNIH-11076644 on NIH RePORTER

What this research studies

This research focuses on understanding the role of the TTYH1 protein in lipid metabolism within brain cells, particularly in relation to aging and neurodegenerative diseases like Alzheimer's. By examining how TTYH1 interacts with another protein, ApoE, and its impact on lipid processing in glial cells, the study aims to uncover the molecular pathways that may contribute to brain cell dysfunction. The researchers will use advanced techniques, including molecular genetics and lipidomic analyses, to explore these mechanisms in both human cells and model organisms.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals at risk for Alzheimer's disease or those experiencing early symptoms of cognitive decline.

Not a fit: Patients with advanced Alzheimer's disease or those without any cognitive impairment may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new insights into the biological processes underlying Alzheimer's disease, potentially paving the way for innovative treatments.

How similar studies have performed: While the specific focus on TTYH1 is novel, previous research has shown that lipid metabolism plays a crucial role in neurodegenerative diseases, indicating potential for success in this area.

Where this research is happening

Newark, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndrome
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.